Radionuclide Therapy

Radionuclide therapy is a type of cancer treatment that uses a special radioactive tracer that is targeted to a specific area of the body. Once injected into the body it travels to the targeted cells and produces high energy particles that can damage cells during the cell division process.  

Our experienced team of Nuclear Medicine Physicians will accept clinical referrals to assess suitability for patient to receive Radionuclide therapy.  Using targeted imaging to determine eligibility, patients will be placed on a treatment plan under the careful management of our multidisciplinary team in collaboration with a patient treating clinician.

The Radionuclide therapy will be performed as a day procedure in our dedicated therapy suite by a team comprising of a Nuclear Medicine Technologist, nurse, and Nuclear Medicine Physician.

MTIC is licenced to use the following isotopes for Radionuclide therapy:‍
177-Lutetium
225-Actinium
161-Terbium